The debate: Should all AF patients see an EP consultant?
|
|
- Shanon Mathews
- 8 years ago
- Views:
Transcription
1 The debate: Should all AF patients see an EP consultant? Pre-debate show of hands in favour of the motion The argument for the motion: Dr Nick Kelland The argument against the motion: Dr Andy McCoye Discussion Post-debate show of hands in favour of the motion Post-debate show of hands of anyone who has altered their referral threshold in view of the debate
2 All patients with AF should be referred to a CRM specialist Dr Nick Kelland Consultant Cardiologist and Electrophysiologist Sheffield Teaching Hospitals Cardiac Update Debate
3 Disclosures Consulting: St Jude Medical. Travel grants: Medtronic; Boston Scientific; SJM. Educational support: Biosense Webster; Cooke Medical; Spectranectics. Speaker fees: Servier; Pfizer and Bristol Myers Squibb.
4 Atrial fibrillation Risk of stroke and death due to thromboembolism Severe symptoms of palpitation/ SOB Uncontrolled rate risks tachycardia related cardiomyopathy
5 What are the implications for stroke in an individual diagnosed with AF? 1 Lifetime risk of stroke after AF diagnosis up to one third 2 Hospital mortality 33% Vs 17% (RR 70%) 3 Hospital LOS 53.7 Vs 49.2days 4 Severe strokes (Barthel index) at 3m 58.3% Vs 16.3% 5 Discharge to nursing home 39% vs 25% 6 Mean cost of hospital stay 11,863 Vs 10,879 7 Higher long term support costs Watkins CL, Leathley MJ, Sharma AK. Stroke Interface Audit: Pre/post discharge audit of stroke services and care in Liverpool and Sefton: Delivery Timeliness and Targeting - 36 month report.
6 GP QOF database 2013/14 Register of AF patients (AF001) 6 Ref last accessed 12/2/15
7 GP QOF database 2013/14 Register of AF patients (AF001) 7 Ref last accessed 12/2/15
8 GP QOF database 2013/14 Register of AF patients (AF001) 8 Ref last accessed 12/2/15
9 QOF AF04 South Yorkshire and Bassetlaw CCG s 2013/ Ref - last accessed 12/2/15
10 QOF AF04 South Yorkshire and Bassetlaw CCG s 2013/2014 CCG Name Overall OAC Achievement rate if CHADS 2 >1 Barnsley 71% Bassetlaw 73% Doncaster 75% Rotherham 65% Sheffield 68% 10 Ref - last accessed 12/2/15
11 QOF AF04 South Yorkshire and Bassetlaw CCG s 2013/2014 CCG Name Overall OAC Achievement rate if CHADS 2 >1 Barnsley 71% Bassetlaw 73% Doncaster 75% Rotherham 65% Sheffield 68%..not doing a good enough job! 11 Ref - last accessed 12/2/15
12 SSNAP data October to December 2014 Ref; - last accessed 28th May
13 SSNAP data October to December 2014 Of those at highest risk low % of AF pts on OAC Ref; - last accessed 28th May
14 Anticoagulation for Stroke Prevention in Non-Valvular Atrial Fibrillation*: Joint primary and secondary care guidance This document provides guidance to primary and secondary care prescribers in selecting the most suitable anticoagulant for each patient and conducting appropriate baseline and ongoing monitoring. Where anticoagulation is commenced in secondary care, physicians are asked to send the Advice letter to GP to communicate the choice and reasons for selection. * Non-valvular AF is defined as AF in the absence of rheumatic mitral stenosis, a mechanical or bioprosthetic heart valve, or mitral valve repair. Patients with aortic valve disease are therefore included in the scope of this guideline. Do not wait for the results of any echocardiogram that may, or may not, be requested before anticoagulating. Echocardiogram will not affect the decision to anticoagulate. Step 1 Baseline investigations (page 2) Step 2 Assess stroke and bleeding risks (CHA 2 DS 2 VASc and HASBLED scores) (page 2) Step 3: Establish which anticoagulants would be appropriate (page 3) including consideration of drug interactions (page 4) Consider whether antiplatelets need to stop or continue (page 4).
15 AF risk of stroke Current rates of OAC use are too low Too many stroke pts, with history of AF, were not taking OAC at presentation Wider uptake of NOACs may help this see new S Yorks guideline New QoF set-up should result in clinical benefit Would greater involvement of secondary care in OAC pathway not improve anticoagulation rates?
16 72yo man Previously F+W HT Some knee pain - referred to orthopaedics for TKR Incidental/ asymptomatic AF referred to CRM clinic Rate 75bpm Echo: mild LVH with preserved systolic function AFEQT overall score =72 Symptom subscore = 95
17 72yo man Previously F+W HT Some knee pain - referred to orthopaedics for TKR Incidental/ asymptomatic AF referred to CRM clinic Rate 75bpm Echo: mild LVH with preserved systolic function AFEQT overall score =72 Symptom subscore = 95 RATE CONTROL + OAC Holter
18 Symptoms AF pts can be severely debilitated by Sx Options for rhythm control: Drugs (often need to be initiated in hospital) Ablation
19
20
21
22 Pt we want to see for rhythm control Severely limited by symptoms clearly shown to be due to AF Limited comorbidities Willing to take small but significant risks of drug/ PVI to increase likelihood of SR
23 57yo man 2 episodes of sudden onset fast palps happened during water immersion (Helicopter emergency training) Documented paf CV with flecainide Structurally normal heart Normal MPS
24 57yo man 2 episodes of sudden onset fast palps happened during water immersion (Helicopter emergency training) Documented paf CV with flecainide Structurally normal heart Normal MPS MEDICAL THERAPY Given flecainide to use as required pill in the pocket
25 55yo man Previous RVOT VT/ VE ablation 2004 Now severe palpitations like a dark cloud Severe symptoms due to paf captured on Holter Structurally normal heart Flecainide and sotalol ineffective and caused bradycardia Rx with dronedarone but still disabling symptoms
26 55yo man Previous RVOT VT/ VE ablation 2004 Now severe palpitations like a dark cloud Severe symptoms due to paf captured on Holter Structurally normal heart Flecainide and sotalol ineffective and caused bradycardia Rx with dronedarone but still disabling symptoms AF ablation THERAPY Underwent Cryoballoon AF ablation with no attacks at 9 months.
27 58yo lady paf with severe symptoms Unable to work Structurally normal heart B blockers/ Flecainide ineffective Amiodarone caused hepatic aminases to rise Dronedarone caused severe nausea AF ablation THERAPY Underwent cryoballoon PVI AF ablation, without much benefit Redo point by point AF ablation under GA 12/12 post procedure, only very occasional and mild palpitations
28 AF-Symptoms AFIP/ NICE 2014 very low threshold for referral to a CRM specialist Most rhythm options require specialist input Suitable patients can get benefit from ablation if performed early enough
29 Rate control - Symptoms of dyspnoea/fatigue often due to uncontrolled VR
30 78yo lady Multiple comorbidity: TIAs; IHD; HT; obesity Severely dilated LA Permanent AF > 5yrs SOB on minimal exertion DC CV on AAD unsuccessful RATE CONTROL Likelihood of successful restoration of SR negligible
31 73yo lady paf with severe symptoms; presyncope/ TLOC Good LV function with large LA Mild PHT Systemic sclerosis + Reynaud s syndrome CHA 2 DS 2 VASc=2; HASBLED=1 Pace and AV node ablation Implant of DDD PPM, then AV node ablation. No more palpitations feels much more confident and independent
32 ATRIUM study High incidence of events many patients will need hospital care Compared to other studies pts under primary care have lower rate of CV, ablation as expected. Clinical Cardiolol 2014
33 High incidence of events many patients needed hospital care
34 ATRIUM study Compared to other studies pts under primary care have lower rate of CV, ablation as expected.
35 Extra capacity required in secondary care In STH 200 pts per year ie one clinic of 6 new pts per week, and one FU clinic. One extra Electrophysiologist In Rotherham 150 pts per year Pts could be automatically referred to the Specialist AF clinic, as soon as an ECG in primary care confirms AF.
36 Summary AF pts need higher rates of OAC this can be delivered by secondary care! Symptomatic patients cannot be effectively treated in primary care Patients with tachycardia related CM need specialist input
37
38
39
40
41 Pt not needed to refer Multiple comorbidities AF is a consequence of other conditions: HT; obesity; mitral valve disease; sepsis; COPD; old age; HF. AF is not the primary problem if they were in SR their main limitations would remain
42 Could be more measured and alter motion All AF patients who need rhythm control should be referred to a CRM specialist Any AF pt with concerns/ issues over OAC should be referred to a CRM specialist
43
Atrial Fibrillation An update on diagnosis and management
Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic
More informationACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY
Care Pathway Triage category ATRIAL FIBRILLATION PATHWAY ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY AF/ FLUTTER IS PRIMARY REASON FOR PRESENTATION YES NO ONSET SYMPTOMS OF AF./../ TIME DURATION OF AF
More informationDifficult Cases in Atrial Fibrillation. Ascot Cardiology GP Symposium April 2014
Difficult Cases in Atrial Fibrillation Ascot Cardiology GP Symposium April 2014 Atrial Fibrillation 1-2% general population 40-50yrs
More informationAtrial Fibrillation: Do We Have A Cure? Raymond Kawasaki, MD AMG Electrophysiology February 21, 2015
Atrial Fibrillation: Do We Have A Cure? Raymond Kawasaki, MD AMG Electrophysiology February 21, 2015 Disclaimer I have no relationships to disclose Do we have a cure for Atrial Fibrillation? The short
More informationNgaire has Palpitations
Ngaire has Palpitations David Heaven Cardiac Electrophysiologist/Heart Rhythm Specialist Middlemore, Auckland City and Mercy Hospitals Auckland Heart Group MCQ Ms A is 45, and a healthy marathon runner.
More informationDISCLOSURE. Atrial Fibrillation Management An Evidence-based Approach OBJECTIVES BACKGROUND AFFIRM 9/16/2015
Death (%) Mortality (%) 9/16/2015 DISCLOSURE Atrial Fibrillation Management An Evidence-based Approach Jonathon Adams, MD, FHRS Relevant Financial Relationship(s) None Off Label Usage None OBJECTIVES What
More informationPalpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust
Palpitations & AF Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations Frequent symptom Less than 50% associated with arrhythmia
More informationTreating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC
Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG
More information2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them?
2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them? Gaetano Senatore DIVISION OF CARDIOLOGY HOSPITAL OF CIRIE
More informationTreatments to Restore Normal Rhythm
Treatments to Restore Normal Rhythm In many instances when AF causes significant symptoms or is negatively impacting a patient's health, the major goal of treatment is to restore normal rhythm and prevent
More informationRecurrent AF: Choosing the Right Medication.
In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/89015.htm Recurrent AF: Choosing the Right Medication. Basamad Z. * Assistant Professor, Department
More informationManagement of Symptomatic Atrial Fibrillation
Management of Symptomatic Atrial Fibrillation John F. MacGregor, MD, FHRS Associate Medical Director, Cardiac Electrophysiology PeaceHealth St. Joseph Medical Center, Bellingham, WA September 18, 2015
More informationAtrial Fibrillation Management Across the Spectrum of Illness
Disclosures Atrial Fibrillation Management Across the Spectrum of Illness NONE Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University Objectives AF Discuss the pathophysiology, diagnosis,
More informationAtrial Fibrillation The Basics
Atrial Fibrillation The Basics Family Practice Symposium Tim McAveney, M.D. 10/23/09 Objectives Review the fundamentals of managing afib Discuss the risks for stroke and the indications for anticoagulation
More informationAtrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center
Atrial Fibrillation Based on ESC Guidelines Moshe Swissa MD Kaplan Medical Center Epidemiology AF affects 1 2% of the population, and this figure is likely to increase in the next 50 years. AF may long
More informationManaging Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular
Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular Mitral Regurgitation Anatomy Mechanisms of MR Presentation Evaluation Management Repair Replace Clip
More informationManaging the Patient with Atrial Fibrillation
Pocket Guide Managing the Patient with Atrial Fibrillation Updated April 2012 Editor Stephen R. Shorofsky, MD, Ph.D. Assistant Editors Anastasios Saliaris, MD Shawn Robinson, MD www.hrsonline.org DEFINITION
More informationHow should we treat atrial fibrillation in heart failure
Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 23/24 Ottobre 2015 How should we treat atrial fibrillation in heart failure Matteo Anselmino Dipartimento Scienze Mediche Città
More informationHow do you decide on rate versus rhythm control?
How do you decide on rate versus rhythm control? Dr. Mark O Neill Consultant Cardiologist & Electrophysiologist Assumptions Camm et al. EHJ 2010;Sept 25 epub Choice of strategy: Criteria for consideration
More informationATRIAL FIBRILLATION: Scope of the Problem. October 2015
ATRIAL FIBRILLATION: Scope of the Problem October 2015 Purpose of the Presentation Review the worldwide incidence and prognosis associated with atrial fibrillation (AF) Identify the types of AF, clinical
More informationManagement of Atrial Fibrillation in Heart Failure
Disadvantages of AV Junction Ablation Persistent AFib- no AV synchrony Ongoing risk of thromboembolism Life-long dependency on pacemaker Comparison of LA Ablation vs. AVN Ablation LA Ablation AVN Ablation
More informationAtrial fibrillation. Quick reference guide. Issue date: June 2006. The management of atrial fibrillation
Quick reference guide Issue date: June 2006 Atrial fibrillation The management of atrial fibrillation Developed by the National Collaborating Centre for Chronic Conditions Contents Contents Patient-centred
More informationAtrial fibrillation/flutter: When to refer, What tests, What meds
Atrial fibrillation/flutter: When to refer, What tests, What meds Warren Smith Green Lane Cardiovascular Service Auckland City Hospital, Auckland, New Zealand Why might it not be a good idea to cardiovert
More informationAtrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology
Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of
More informationNursing Care and Considerations for Patients with Atrial Fibrillation. Kris Kinghorn RN, MSN, ANP-BC
Nursing Care and Considerations for Patients with Atrial Fibrillation Kris Kinghorn RN, MSN, ANP-BC Case Study 66 y/o female (Mrs. Olus A. Blader) Admitted with c/o palpitations and lightheadedness PMH:
More informationATRIAL FIBRILLATION IN THE 21 ST CENTURY TIMOTHY DOWLING, D.O. FAMILY PHYSICIAN
ATRIAL FIBRILLATION IN THE 21 ST CENTURY TIMOTHY DOWLING, D.O. FAMILY PHYSICIAN GOALS AND OBJECTIVES At The end of this talk you should understand: What is Atrial Fibrillation Causes of Atrial Fibrillation
More informationNORTHERN NETWORK OF CARDIAC CARE GUIDELINES FOR THE DETECTION AND MANAGEMENT OF ATRIAL FIBRILLATION (AF)
NORTHERN NETWORK OF CARDIAC CARE GUIDELINES FOR THE DETECTION AND MANAGEMENT OF ATRIAL FIBRILLATION (AF) These notes should be read in conjunction with the summary algorithms July 2007 CONTENTS 1. Introduction
More informationManagement of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39
Management of ATRIAL FIBRILLATION in general practice 22 BPJ Issue 39 What is atrial fibrillation? Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care. It is often
More informationMaking the Health Check work for you
Making the Health Check work for you Atrial Fibrillation and the GRASP toolkit (Guidance on Risk Assessment and Stroke Prevention ) Dr. Indira Natarajan Consultant Stroke Physician University Hospital
More informationAtrial Fibrillation Peter Santucci, MD Revised May, 2008
Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial fibrillation (AF) is an irregular, disorganized rhythm characterized by a lack of organized mechanical atrial activity. The atrial rate is
More informationPresenter Disclosure Information
2:15 3 pm Managing Arrhythmias in Primary Care Presenter Disclosure Information The following relationships exist related to this presentation: Raul Mitrani, MD, FACC, FHRS: Speakers Bureau for Medtronic.
More informationThe Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?
The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It? Indiana Chapter-ACC 17 th Annual Meeting Indianapolis, Indiana October 19, 2013 Deepak Bhakta MD FACC FACP FAHA FHRS CCDS Associate
More informationAtrial Fibrillation (AF) March, 2013
Atrial Fibrillation (AF) March, 2013 This handout is meant to help with discussions about the condition, and it is not a complete discussion of AF. We hope it will complement your appointment with one
More informationAnticoagulants in Atrial Fibrillation
Anticoagulants in Atrial Fibrillation Starting and Stopping Them Safely Carmine D Amico, D.O. Overview Learning objectives Introduction Basic concepts Treatment strategy & options Summary 1 Learning objectives
More informationThe intensity and duration of monitoring should be determined by the clinical need to establish the diagnosis
Cardiology and Vascular Medicine ESC Update Programme in Cardiology Rotterdam, June 12 th, 2012 Atrial Fibrillation ESC Guidelines: Paroxysmal Atrial Fibrillation Irene Savelieva St George s University
More informationCurrent Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose
Current Management of Atrial Fibrillation Mary Macklin, MSN, APRN Concord Hospital Cardiac Associates DISCLOSURES I have no financial conflicts to disclose Book Women: Fit at Fifty. A Guide to Living Long.
More informationCOVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION
COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION Question: How should the EGBS Coverage Guidance regarding ablation for atrial fibrillation be applied to the Prioritized List? Question source: Evidence
More informationAtrial Fibrillation - management AF in primary care
Care map information Information resources for patients and carers Updates to this care map Hauora Maori Pacific Clinical presentation AF
More informationAtrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015
Atrial Fibrillation: Drugs, Ablation, or Benign Neglect Robert Kennedy, MD October 10, 2015 Definitions 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary.
More informationATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation
More informationBlood thinning (anticoagulation) in atrial fibrillation (AF)
AF A Blood thinning (anticoagulation) in atrial fibrillation (AF) Providing information, support and access to established, new or innovative treatments for atrial fibrillation www.afa.org.uk Registered
More informationCardioversion for. Atrial Fibrillation. Your Heart s Electrical System Cardioversion Living with Atrial Fibrillation
Cardioversion for Atrial Fibrillation Your Heart s Electrical System Cardioversion Living with Atrial Fibrillation When You Have Atrial Fibrillation You ve been told you have a heart condition called atrial
More informationRATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent
More informationNICE clinical guideline 180: Atrial fibrillation Prescribing and medicines optimisation issues
NICE clinical guideline 180: Atrial fibrillation Prescribing and medicines optimisation issues Andy Hutchinson Medicines Education Technical Adviser NICE Medicines and Prescribing Centre Note: this is
More informationNon- Valvular Atrial Fibrillation and Stroke Prevention: Which OAC Do I Choose. Warfarin vs the NOACs
Non- Valvular Atrial Fibrillation and Stroke Prevention: Which OAC Do I Choose Warfarin vs the NOACs Dr. Lori McIntosh D.O. Board Certified Neurologist Objectives Be able to list the current options of
More informationEpisode 20 Atrial fibrillation Prepared by Dr. Lucas Chartier
Episode 20 Atrial fibrillation Prepared by Dr. Lucas Chartier Most common dysrhythmia seen in ED, and incidence increasing with ageing population Presentation Common presentations: younger patients often
More informationTABLE 1 Clinical Classification of AF. New onset AF (first detected) Paroxysmal (<7 days, mostly < 24 hours)
Clinical Practice Guidelines for the Management of Patients With Atrial Fibrillation Deborah Ritchie RN, MN, Robert S Sheldon MD, PhD Cardiovascular Research Group, University of Calgary, Alberta Partly
More informationAbout the British Heart Foundation
Atrial fibrillation About the British Heart Foundation The British Heart Foundation (BHF) is the nation s heart charity, saving lives through pioneering research, patient care and vital information. What
More informationNovel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations
Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations Dardo E. Ferrara MD Cardiac Electrophysiology North Cascade Cardiology PeaceHealth Medical Group Which anticoagulant
More informationAtrial Fibrillation New Treatment, New Hope. Atrial Fibrillation It Just Sucks. Atrial Fibrillation Disclosure Information 1/30/2014
New Treatment, New Hope Emerging Concepts And Novel Management Strategies James J. Merrill, MD February 1, 2014 Wellmont CVA Heart Institute Kingsport, TN It Just Sucks We Don t Know What Causes It Or
More informationAtrial Fibrillation and Heart Failure: A Cause or a Consequence
Atrial Fibrillation and Heart Failure: A Cause or a Consequence Rajat Deo, MD, MTR Assistant Professor of Medicine Division of Cardiology, Electrophysiology Section University of Pennsylvania November
More informationINFORMATION FOR PATIENTS AND FAMILIES A Patient s Guide to Living with Atrial Fibrillation
INFORMATION FOR PATIENTS AND FAMILIES A Patient s Guide to Living with Atrial Fibrillation 30 Bond Street, Toronto, ON M5B 1W8 Canada 416.864.6060 stmichaelshospital.com Form No. XXXXX Dev. XX/XXXX GOALS
More informationNew Oral Anticoagulants. How safe are they outside the trials?
New Oral Anticoagulants How safe are they outside the trials? Objectives The need for anticoagulant therapy Indications for anticoagulation Traditional anticoagulant therapies Properties of new oral anticoagulants
More informationAtrial Fibrillation 2012: Latest Approaches to Diagnosis, Treatment, and Stroke Prevention
Atrial Fibrillation 2012: Latest Approaches to Diagnosis, Treatment, and Stroke Prevention Michael G. Clark, PA-C, MPAS, Ph.D., AACC Fisher Cardiology and Electrophysiology Bedford, Texas Disclosures Speakers
More informationPractical Rate and Rhythm Management of Atrial Fibrillation
Practical Rate and Rhythm Management of Atrial Fibrillation pocket guide UPDATED FEBRUARY 2013 Adapted from the ACCF/AHA/HRS 2011 Focused Updates Incorporated into the ACC/AHA/ESC Guidelines for the Management
More informationAtrial Fibrillation (AF) Explained
James Paget University Hospitals NHS Foundation Trust Atrial Fibrillation (AF) Explained Patient Information Contents What are the symptoms of atrial fibrillation (AF)? 3 Normal heartbeat 4 How common
More informationAblation For Atrial Fibrillation. Bill Petrellis Electrophysiologist
Ablation For Atrial Fibrillation Bill Petrellis Electrophysiologist AF is the most common arrhythmia in the Western world Prevalence 1.1% in Australia conservative estimate - 240,000 June 2009 AF is an
More informationDorset Cardiac Centre
P a g e 1 Dorset Cardiac Centre Patients with Atrial Fibrillation/Flutter undergoing DC Cardioversion or Ablation procedures- Guidelines for Novel Oral Anti-coagulants (NOACS) licensed for this use February
More informationAnticoagulation: How Do I Pick From All the Choices? Jeffrey H. Neuhauser, DO, FACC BHHI Primary Care Symposium February 28, 2014
Anticoagulation: How Do I Pick From All the Choices? Jeffrey H. Neuhauser, DO, FACC BHHI Primary Care Symposium February 28, 2014 Atrial Fibrillation 2 Atrial Fibrillation The most common arrhythmia encountered
More information2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY
Measure #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS,
More informationWhat Can I Do about Atrial Fibrillation (AF)?
Additional Device Information 9529 Reveal XT Insertable Cardiac Monitor The Reveal XT Insertable Cardiac Monitor is an implantable patientactivated and automatically activated monitoring system that records
More informationProtocol for the management of atrial fibrillation in primary care
Protocol for the management of atrial fibrillation in primary care Protocol for the management of atrial fibrillation in primary care Contents Page no Definition 2 Classification of AF 2 3 Identification
More informationTachyarrhythmias (fast heart rhythms)
Patient information factsheet Tachyarrhythmias (fast heart rhythms) The normal electrical system of the heart The heart has its own electrical conduction system. The conduction system sends signals throughout
More informationHow do you decide on rate versus rhythm control?
Heart Rhythm Congress 2014 How do you decide on rate versus rhythm control? Dr Ed Duncan Consultant Cardiologist & Electrophysiologist Define Rhythm Control DC Cardioversion Pharmacological AFFIRM study
More informationNew in Atrial Fibrillation
New in Atrial Fibrillation September 2011 Stroke prevention more options Rhythm Control -drugs - alternatives to drugs; ablation Rate Control - pace + ablate A-FIB Dell Stroke Risk AFib Two Principles
More informationATRIAL FIBRILLATION RATE VS RHYTHM CONTROL NCVH BIRMINGHAM 2014
ATRIAL FIBRILLATION RATE VS RHYTHM CONTROL NCVH BIRMINGHAM 2014 Facts 4 million or so people have atrial fibrillation 16 billion dollars spent yearly in USA 30% of strokes attributable to AF and AFL 3-5
More informationSTROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:
STROKE PREVENTION IN ATRIAL FIBRILLATION TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention
More informationAtrial Fibrillation: The heart of the matter
Atrial Fibrillation: The heart of the matter This booklet has been written especially for people with atrial fibrillation (AF), a heart condition often described as an irregular heartbeat (also known
More informationSTROKE PREVENTION IN ATRIAL FIBRILLATION
STROKE PREVENTION IN ATRIAL FIBRILLATION OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention of ischemic stroke and arterial thromboembolism in patients
More informationAtrial Fibrillation Cardiac rate control or rhythm control could be the key to AF therapy
Cardiac rate control or rhythm control could be the key to AF therapy Recent studies have proven that an option of pharmacologic and non-pharmacologic therapy is available to patients who suffer from AF.
More informationService Specification Template Department of Health, updated June 2015
Service Specification Template Department of Health, updated June 2015 Service Specification No. : 2 Service: Commissioner Lead: Provider Lead: Period: Anti-coagulation monitoring Date of Review: 31 st
More informationAtrial Fibrillation and Anticoagulants
York Teaching Hospital NHS Foundation Trust Atrial Fibrillation and Anticoagulants A guide to your diagnosis and treatment Information for patients, relatives and carers For more information, please contact:
More informationCatheter Ablation. A Guided Approach for Treating Atrial Arrhythmias
Catheter Ablation A Guided Approach for Treating Atrial Arrhythmias A P A T I E N T H A N D B O O K This brochure will provide an overview of atrial arrhythmias (heart rhythm problems affecting the upper
More informationGRASP-AF Audit Tool Instructional Guide
GRASP-AF Audit Tool Instructional Guide GRASP-AF is funded and supported by NHS Improving Quality. The GRASP-AF tool has been developed by PRIMIS in partnership with NHSIQ. Document reviewed by PRIMIS
More informationNew Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013
New Treatments for Stroke Prevention in Atrial Fibrillation John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 Classification Paroxysmal atrial fibrillation (AF) Last < 7
More information9/5/14. Objectives. Atrial Fibrillation (AF)
Novel Anticoagulation for Prevention of Stroke in Patients with Atrial Fibrillation Objectives 1. Review current evidence on use of warfarin in individuals with atrial fibrillation 2. Compare the three
More informationDabigatran: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF
Leeds Dabigatran: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF Amber Drug Level 3 (amber drug with monitoring requirements) We have started your
More informationCardiology Update 2014
Cardiology Update 2014 Update on the Novel Oral Anticoagulants (NOACS) Raymond Kawasaki, MD AMG Cardiology December 6, 2014 Disclosures I have no disclosures relevant to this presentation Contents I. The
More informationNational Medicines Information Centre
National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL 01-4730589 or 1850-727-727 FAX 01-4730596 www.nmic.ie THE CONTEMPORARY MANAGEMENT OF ATRIAL FIBRILLATION VOLUME 12 NUMBER 3 2006
More informationAtrial fibrillation (AF) care pathways. for the primary care physicians
Atrial fibrillation (AF) care pathways for the primary care physicians by University of Minnesota Physicians Heart, October, 2011 Evaluation by the primary care physician: 1. Comprehensive history and
More informationThe new Heart Failure pathway
The new Heart Failure pathway An integrated and seamless Strategy Dr Sunil Balani Definition of Heart Failure The inability of the heart to pump blood at a rate commensurate with the requirements of metabolising
More informationHERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below
Name: generic (trade) Rivaroxaban (Xarelto ) HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below What it is Indications
More informationAtrial fibrillation (AF) patient information
AF A Atrial fibrillation (AF) patient information Providing information, support and access to established, new or innovative treatments for Atrial Fibrillation www.atrialfibrillation-au.org Glossary Antiarrhythmic
More informationSurgeons Role in Atrial Fibrillation
Atrial Fibrillation Surgeons Role in Atrial Fibrillation Steven J Feldhaus, MD, FACS 2015 Cardiac Symposium September 18, 2015 Stages of Atrial Fibrillation Paroxysmal (Intermittent) Persistent (Continuous)
More informationAtrial Fibrillation The High Risk Obese Patient
Atrial Fibrillation The High Risk Obese Patient Frederick Schaller, D.O.,F.A.C.O.I. Professor and Vice Dean Touro University Nevada A 56 year old male with a history of hypertension and chronic stable
More informationwww.irishheart.ie ATRIAL FIBRILLATION AND YOU An information booklet for people living with Atrial Fibrillation (a type of irregular heart beat).
www.irishheart.ie ATRIAL FIBRILLATION AND YOU An information booklet for people living with Atrial Fibrillation (a type of irregular heart beat). Contents Introduction 5 Produced by the Irish Heart Foundation
More informationAtrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Outline Atrial Fibrillation What is it? What are the associated
More informationPRACTICAL APPROACH TO SVT. Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia
PRACTICAL APPROACH TO SVT Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia CONDUCTION SYSTEM OF THE HEART SA node His bundle Left bundle AV node Right
More informationHot Topics: Current PFO Recommendations and Loop Monitoring/Cryptogenic Stroke.
Hot Topics: Current PFO Recommendations and Loop Monitoring/Cryptogenic Stroke. Favoriteplus.com www.heartrhythmcharity.org.uk www.forbes.com Victor J. Mazza, MD Assistant Professor of Medicine Cardiology,
More informationNew Treatment Guidelines in Atrial Fibrillation and Updates on NOACs
New Treatment Guidelines in Atrial Fibrillation and Updates on NOACs Dean Schillinger MD Professor of Medicine University of California, San Francisco San Francisco General Hospital & Trauma Center Disclosures
More informationNICE TA 275: Apixaban for the prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation
Service Notification in response to DHSSPS endorsed NICE Technology Appraisals NICE TA 275: Apixaban for the prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation 1
More informationIntroduction 2/9/2015
Thomas Haffey, D.O. FACC, FACOI, FNLA, CSOM February, 2015 Atrial Tachycardias Diagram summarizing types of atrial tachycardias often encountered in patients with a history of AF, including those seen
More informationAnticoagulation Therapy Update
Anticoagulation Therapy Update JUDY R. WALLING, FNP-BC ARRHYTHMIA MANAGEMENT MUSC CARDIOLOGY Outline Who do we anticoagulate? Review classes of Anticoagulants Review examples of Anticoagulants Review CHADS2
More informationAtrial fibrillation (non-valvular) and reducing the risk of a stroke Management Options Brief Decision Aid
Atrial fibrillation (non-valvular) and reducing the risk of a stroke Management Options Brief Decision Aid Atrial fibrillation (AF) increases your risk of having a stroke (a blood clot in the brain). From
More informationAtrial fibrillation: medicines to help reduce your risk of a stroke what are the options?
Patient decision aid Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options? http://guidance.nice.org.uk/cg180/patientdecisionaid/pdf/english Published: June 2014 About
More informationSetting up a Blackout Service
Setting up a Blackout Service Jayne Mudd, Nurse Consultant, Cardiac Rhythm Management James Cook University Hospital, Middlesbrough South Tees NHS Foundation Trust NECVN: Population of approximately 2.8
More informationHow to control atrial fibrillation in 2013 The ideal patient for a rate control strategy
How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy L. Pison, MD Advances in Cardiac Arrhythmias and Great Innovations in Cardiology - Torino, September 28 th 2013
More informationNovartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI)
Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI) Highlights from Prescribing Information - the link to the full text PI is as follows: http://www.pharma.us.novartis.com/product/pi/pdf/gilenya.pdf
More informationNAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3
1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications
More information